Financial Data and Key Metrics Changes - Consolidated net sales increased by 21% year over year in Q3, reaching $66.7 million, driven by growth in the Canadian cannabis segment and contributions from recreational cannabis sales in the Netherlands [4][17] - Net income from continuing operations was $10.8 million, or $0.09 per share, an increase of nearly 10% sequentially compared to the previous quarter [4][17] - Adjusted EBITDA from continuing operations was $20.7 million, resulting in an adjusted EBITDA margin of 31%, compared to 8.5% in Q3 of the previous year [4][17] - Cash flow from operations improved to $24.4 million, compared to $6.1 million in Q3 of the previous year [4][18] Business Line Data and Key Metrics Changes - Canadian cannabis business net sales grew by 29% year over year, reaching CAD 64.1 million, driven by strong performance in targeted channels and improved pricing [5][18] - Canadian cannabis gross margin was 56%, up from 26% in Q3 of the previous year, exceeding the targeted range of 30%-40% [11][19] - Adjusted EBITDA for Canadian cannabis improved by 309% year over year to CAD 26.6 million, resulting in an adjusted EBITDA margin of 41% [11][19] - The Netherlands cannabis operations generated EUR 3.6 million in sales with adjusted EBITDA of EUR 1.3 million, marking significant increases quarter over quarter [12][20] Market Data and Key Metrics Changes - The international medical cannabis business saw over 750% sales growth year over year, with significant contributions from Germany [5][18] - Village Farms is now believed to be the largest exporter of medical cannabis to Europe, with a strong position to expand into new markets [8][9] - Canadian cannabis retail sales were in line with expectations, with stronger contribution margins from retail branded sales [6][18] Company Strategy and Development Direction - The company is focused on scaling its cannabis production capabilities, with a 40 metric ton capacity expansion project underway, expected to increase annual production capacity in Canada by approximately 33% [10][11] - The company aims to continue supporting growth in Canada and abroad, with plans to expand into multiple new international jurisdictions [9][10] - The management emphasizes a culture of cost discipline and continuous improvement to drive future growth [25] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the sustainability of positive trends across the business, citing competitive strengths and growth catalysts [4][25] - The company anticipates continued growth in revenue and EBITDA, supported by operational and manufacturing expertise [25] - Management highlighted the importance of consistent product quality and operational excellence in maintaining competitive advantage [30] Other Important Information - The company closed the quarter with approximately $88 million in cash, reflecting an increase of nearly $23 million since the end of Q2 [16][22] - A share repurchase program was implemented as part of a balanced approach to capital allocation to drive shareholder returns [16][23] Q&A Session Summary Question: About cannabis gross margin improvement - Management noted improved efficiency, higher crop yields, favorable pricing, and international export sales as key drivers for the sequential gross margin improvement [26][27] Question: Competitive environment and market share in international markets - Management indicated that consistent high-quality production and EU GMP certification have positioned the company well to gain market share, particularly in Germany [30][34] Question: Performance and outlook for the Netherlands - Management confirmed that long-term gross margin targets for the Netherlands are similar to those for Canadian cannabis, emphasizing the startup nature of the operations [31][32] Question: Regulatory changes and opportunities in Texas - Management expressed excitement about the regulatory changes in Texas and confirmed that they are exploring suitable structures to maintain their NASDAQ listing while considering M&A opportunities [36][37] Question: Quebec's importance and regulatory changes - Management acknowledged Quebec's significance but clarified that it does not account for 40% of total cannabis revenue, while highlighting the potential benefits from recent regulatory changes [38][39] Question: Competitive landscape in the Netherlands - Management noted that while some competitors face challenges, the company is focused on expanding its capacity and is well-positioned for future growth [40]

Market Performance - The S&P 500 increased by 6.4%, the Dow Jones rose by 4.2%, the Nasdaq advanced by 9.9%, and the Russell 2000 gained 10.9% in Q3 2025, with small caps receiving particular attention [1] - The Russell 2000 surged approximately 7% in August, marking its fourth consecutive monthly gain and the strongest streak in over four years [1] Economic Indicators - The U.S. economy grew at a robust 3.8% pace in Q2 2025, driven by stronger consumer spending, which was an upward revision from the previously reported 3.3% growth [2][3] - The U.S. added 22,000 jobs in August 2025, which was lower than the revised 79,000 in July and below market forecasts of 75,000 [4] - The annual inflation rate in the U.S. rose to 2.9% in August 2025, the highest since January, after remaining at 2.7% in June and July [4] Federal Reserve Actions - The Federal Reserve implemented its first rate cut of 2025 in September, with a high probability of a further 25-basis point cut in the upcoming October meeting [5] Trade and Tariff Developments - President Trump announced new tariffs ranging from 30% to 100% on various imported goods, effective October 1, 2025, with exemptions for certain drug manufacturers [6] Sector Highlights - The AI sector remains strong, with notable deals from NVIDIA involving Intel, Open AI, and Alibaba, although concerns about the pace of AI payoffs persist [7] - Bitcoin mining ETFs saw significant gains, with CoinShares Bitcoin Mining ETF up 116.4% and Grayscale Bitcoin Miners ETF up 69.3%, driven by increased institutional adoption [9] - Cannabis ETFs also performed well, with Roundhill Cannabis ETF up 91.8% and AdvisorShares Pure US Cannabis ETF up 84.5%, following hints from President Trump about potential reclassification of marijuana [10] - Rare earth sector saw VanEck Rare Earth/Strategic Metals ETF increase by 67.6%, with Lithium Americas Inc. shares jumping about 90% after government investment announcements [11] - Ethereum prices surged by 57% in Q3 2025, with Grayscale Ethereum Mini Trust ETF up 60.9% and Bitwise Ethereum ETF up 60.8%, driven by strong institutional demand [12]